REXAHN PHARMACEUTICALS, INC. 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed May 3, 2006
Insider Transaction Report
Form 4
Ahn Inok
DirectorTreasurer10% Owner
Transactions
- Award
Stock option (right to buy)
2005-12-08+500,000→ 500,000 totalExercise: $0.80Exp: 2015-01-20→ Common stock (500,000 underlying) - Disposition to Issuer
Stock option (right to buy)
2005-12-08−500,000→ 0 totalExercise: $0.25Exp: 2015-01-20→ Common stock (500,000 underlying) - Award
Stock option (right to buy)
2005-12-08+1,000,000→ 1,000,000 total(indirect: By Spouse)Exercise: $0.80Exp: 2015-01-20→ Common stock (1,000,000 underlying) - Disposition to Issuer
Stock option (right to buy)
2005-12-08−1,000,000→ 0 total(indirect: By Spouse)Exercise: $0.24Exp: 2015-01-20→ Common stock (1,000,000 underlying)
Footnotes (2)
- [F1]The options vest and become exercisable as to 30% of the options on January 20, 2006; another 30% of the options on January 20, 2007; and the remaining 40% of the options on January 20, 2008.
- [F2]The transaction involved an amendment of outstanding options to change the exercise price from $0.24 to $0.80, resulting in the deemed cancellation of the original options and the grant of replacement options with the same vesting and exercisability terms as the cancelled options.